These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 28662684)

  • 21. Glucose or intermittent high-intensity exercise in glargine/glulisine users with T1DM.
    Dubé MC; Lavoie C; Weisnagel SJ
    Med Sci Sports Exerc; 2013 Jan; 45(1):3-7. PubMed ID: 22895370
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Glucose and Counterregulatory Responses to Exercise in Adults With Type 1 Diabetes and Impaired Awareness of Hypoglycemia Using Closed-Loop Insulin Delivery: A Randomized Crossover Study.
    Lee MH; Vogrin S; Paldus B; Jayawardene D; Jones HM; McAuley SA; Obeyesekere V; Gooley J; La Gerche A; MacIsaac RJ; Sundararajan V; Jenkins AJ; Ward GM; O'Neal DN
    Diabetes Care; 2020 Feb; 43(2):480-483. PubMed ID: 31796571
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of glycemic variability on counterregulatory hormone responses to hypoglycemia in young children and adolescents with type 1 diabetes.
    Alghothani N; Dungan KM
    Diabetes Technol Ther; 2011 Nov; 13(11):1085-9. PubMed ID: 21770764
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Insulin during pregnancy, labour and delivery.
    de Valk HW; Visser GH
    Best Pract Res Clin Obstet Gynaecol; 2011 Feb; 25(1):65-76. PubMed ID: 21186142
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Randomized Clinical Trial of the Effect of Continuous Glucose Monitoring on Nocturnal Hypoglycemia, Daytime Hypoglycemia, Glycemic Variability, and Hypoglycemia Confidence in Persons with Type 1 Diabetes Treated with Multiple Daily Insulin Injections (GOLD-3).
    Ólafsdóttir AF; Polonsky W; Bolinder J; Hirsch IB; Dahlqvist S; Wedel H; Nyström T; Wijkman M; Schwarcz E; Hellman J; Heise T; Lind M
    Diabetes Technol Ther; 2018 Apr; 20(4):274-284. PubMed ID: 29608107
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influence of Insulin Application Time and High-Intensity Intermittent Exercise on Hypoglycemic Risk in Adolescents With Type 1 Diabetes.
    de Lima VA; Cordeiro GR; Mascarenhas LPG; França SN; Decimo JP; de Leão AAP; Fritz CK; Leite N
    Pediatr Exerc Sci; 2022 Feb; 34(1):6-12. PubMed ID: 34311442
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The 10-s maximal sprint: a novel approach to counter an exercise-mediated fall in glycemia in individuals with type 1 diabetes.
    Bussau VA; Ferreira LD; Jones TW; Fournier PA
    Diabetes Care; 2006 Mar; 29(3):601-6. PubMed ID: 16505513
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of near physiologic insulin therapy on hypoglycemia counterregulation in type-1 diabetes.
    Bischof MG; Bernroider E; Ludwig C; Kurzemann S; Kletter K; Waldhäusl W; Roden M
    Horm Res; 2001; 56(5-6):151-8. PubMed ID: 11910200
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Single Load of Fructose Attenuates the Risk of Exercise-Induced Hypoglycemia in Adults With Type 1 Diabetes on Ultra-Long-Acting Basal Insulin: A Randomized, Open-Label, Crossover Proof-of-Principle Study.
    Kosinski C; Herzig D; Laesser CI; Nakas CT; Melmer A; Vogt A; Vogt B; Laimer M; Bally L; Stettler C
    Diabetes Care; 2020 Sep; 43(9):2010-2016. PubMed ID: 32591421
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Negative binomial meta-regression analysis of combined glycosylated hemoglobin and hypoglycemia outcomes across eleven Phase III and IV studies of insulin glargine compared with neutral protamine Hagedorn insulin in type 1 and type 2 diabetes mellitus.
    Mullins P; Sharplin P; Yki-Jarvinen H; Riddle MC; Haring HU
    Clin Ther; 2007 Aug; 29(8):1607-19. PubMed ID: 17919543
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Flexible insulin therapy with a hybrid regimen of insulin degludec and continuous subcutaneous insulin infusion with pump suspension before exercise in physically active adults with type 1 diabetes (FIT Untethered): a single-centre, open-label, proof-of-concept, randomised crossover trial.
    Aronson R; Li A; Brown RE; McGaugh S; Riddell MC
    Lancet Diabetes Endocrinol; 2020 Jun; 8(6):511-523. PubMed ID: 32445738
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Counterregulatory hormone responses after long-term continuous subcutaneous insulin infusion with lispro insulin.
    Tsui EY; Chiasson JL; Tildesley H; Barnie A; Simkins S; Strack T; Zinman B
    Diabetes Care; 1998 Jan; 21(1):93-6. PubMed ID: 9538976
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fasted High-Intensity Interval and Moderate-Intensity Exercise Do Not Lead to Detrimental 24-Hour Blood Glucose Profiles.
    Scott SN; Cocks M; Andrews RC; Narendran P; Purewal TS; Cuthbertson DJ; Wagenmakers AJM; Shepherd SO
    J Clin Endocrinol Metab; 2019 Jan; 104(1):111-117. PubMed ID: 30252054
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential effects of insulin detemir and neutral protamine Hagedorn (NPH) insulin on hepatic glucose production and peripheral glucose uptake during hypoglycaemia in type 1 diabetes.
    Smeeton F; Shojaee Moradie F; Jones RH; Westergaard L; Haahr H; Umpleby AM; Russell-Jones DL
    Diabetologia; 2009 Nov; 52(11):2317-23. PubMed ID: 19707744
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of insulin therapy and dietary adjustments on safety and performance during simulated soccer tests in people with type 1 diabetes: study protocol for a randomized controlled trial.
    Calvo-Marín J; Torrealba-Acosta G; Campbell M; Gaboury J; Ali A; Chen-Ku CH
    Trials; 2017 Jul; 18(1):338. PubMed ID: 28728559
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relationship between Optimum Mini-doses of Glucagon and Insulin Levels when Treating Mild Hypoglycaemia in Patients with Type 1 Diabetes - A Simulation Study.
    Ranjan A; Wendt SL; Schmidt S; Madsbad S; Holst JJ; Madsen H; Knudsen CB; Jørgensen JB; Nørgaard K
    Basic Clin Pharmacol Toxicol; 2018 Mar; 122(3):322-330. PubMed ID: 28922582
    [TBL] [Abstract][Full Text] [Related]  

  • 37. No Disadvantage to Insulin Pump Off vs Pump On During Intermittent High-Intensity Exercise in Adults With Type 1 Diabetes.
    Zaharieva DP; Cinar A; Yavelberg L; Jamnik V; Riddell MC
    Can J Diabetes; 2020 Mar; 44(2):162-168. PubMed ID: 31416695
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Blood glucose awareness training and epinephrine responses to hypoglycemia during intensive treatment in type 1 diabetes.
    Kinsley BT; Weinger K; Bajaj M; Levy CJ; Simonson DC; Quigley M; Cox DJ; Jacobson AM
    Diabetes Care; 1999 Jul; 22(7):1022-8. PubMed ID: 10388961
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A Randomized Crossover Trial Comparing Glucose Control During Moderate-Intensity, High-Intensity, and Resistance Exercise With Hybrid Closed-Loop Insulin Delivery While Profiling Potential Additional Signals in Adults With Type 1 Diabetes.
    Paldus B; Morrison D; Zaharieva DP; Lee MH; Jones H; Obeyesekere V; Lu J; Vogrin S; La Gerche A; McAuley SA; MacIsaac RJ; Jenkins AJ; Ward GM; Colman P; Smart CEM; Seckold R; King BR; Riddell MC; O'Neal DN
    Diabetes Care; 2022 Jan; 45(1):194-203. PubMed ID: 34789504
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Divergent Hypoglycemic Effects of Hepatic-Directed Prandial Insulin: A 6-Month Phase 2b Study in Type 1 Diabetes.
    Klonoff D; Bode B; Cohen N; Penn M; Geho WB; Muchmore DB
    Diabetes Care; 2019 Nov; 42(11):2154-2157. PubMed ID: 31551249
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.